117 related articles for article (PubMed ID: 8757426)
1. Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome.
Chirgwin KD; Feldman J; Muneyyirci-Delale O; Landesman S; Minkoff H
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):489-94. PubMed ID: 8757426
[TBL] [Abstract][Full Text] [Related]
2. Effect of HIV-1 infection and increasing immunosuppression on menstrual function.
Ezechi OC; Jogo A; Gab-Okafor C; Onwujekwe DI; Ezeobi PM; Gbajabiamila T; Adu RA; Audu RA; Musa AZ; Salu OB; Meschack E; Herbertson E; Odunukwe N; Idigbe OE
J Obstet Gynaecol Res; 2010 Oct; 36(5):1053-8. PubMed ID: 21058440
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of menstruation in women infected with human immunodeficiency virus.
Ellerbrock TV; Wright TC; Bush TJ; Dole P; Brudney K; Chiasson MA
Obstet Gynecol; 1996 Jun; 87(6):1030-4. PubMed ID: 8649685
[TBL] [Abstract][Full Text] [Related]
4. Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women.
Massad LS; Evans CT; Minkoff H; Watts DH; Greenblatt RM; Levine AM; Anastos K; Young M; Seifer DB; Golub E; Cohen M
J Womens Health (Larchmt); 2006 Jun; 15(5):591-8. PubMed ID: 16796486
[TBL] [Abstract][Full Text] [Related]
5. Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders.
Fumaz CR; Muñoz-Moreno JA; Ferrer MJ; Negredo E; Pérez-Alvarez N; Tarrats A; Clotet B
AIDS Patient Care STDS; 2009 Jun; 23(6):463-8. PubMed ID: 19519230
[TBL] [Abstract][Full Text] [Related]
6. Menstrual symptoms in women infected by the human immunodeficiency virus.
Shah PN; Smith JR; Wells C; Barton SE; Kitchen VS; Steer PJ
Obstet Gynecol; 1994 Mar; 83(3):397-400. PubMed ID: 8127532
[TBL] [Abstract][Full Text] [Related]
7. Menstrual function after tubal sterilization.
Wilcox LS; Martinez-Schnell B; Peterson HB; Ware JH; Hughes JM
Am J Epidemiol; 1992 Jun; 135(12):1368-81. PubMed ID: 1510083
[TBL] [Abstract][Full Text] [Related]
8. Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus.
Harlow SD; Cohen M; Ohmit SE; Schuman P; Cu-Uvin S; Lin X; Greenblatt R; Gurtman A; Khalsa A; Minkoff H; Young MA; Klein RS
Am J Obstet Gynecol; 2003 Apr; 188(4):881-6. PubMed ID: 12712080
[TBL] [Abstract][Full Text] [Related]
9. The association of behavior and lifestyle factors with menstrual symptoms.
Kritz-Silverstein D; Wingard DL; Garland FC
J Womens Health Gend Based Med; 1999 Nov; 8(9):1185-93. PubMed ID: 10595332
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
Dolan SE; Kanter JR; Grinspoon S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2938-45. PubMed ID: 16735489
[TBL] [Abstract][Full Text] [Related]
11. Menstrual cycle characteristics in women with persistent schizophrenia.
Gleeson PC; Worsley R; Gavrilidis E; Nathoo S; Ng E; Lee S; Kulkarni J
Aust N Z J Psychiatry; 2016 May; 50(5):481-7. PubMed ID: 26070315
[TBL] [Abstract][Full Text] [Related]
12. The influence of stress on the menstrual cycle among newly incarcerated women.
Allsworth JE; Clarke J; Peipert JF; Hebert MR; Cooper A; Boardman LA
Womens Health Issues; 2007; 17(4):202-9. PubMed ID: 17560123
[TBL] [Abstract][Full Text] [Related]
13. Complications of use of intrauterine devices among HIV-1-infected women.
Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
[TBL] [Abstract][Full Text] [Related]
14. Endocrine function in HIV-infected women.
Hinz S; McCormack D; van der Spuy ZM
Gynecol Endocrinol; 2002 Feb; 16(1):33-8. PubMed ID: 11915579
[TBL] [Abstract][Full Text] [Related]
15. Influence of medical conditions and lifestyle factors on the menstrual cycle.
Rowland AS; Baird DD; Long S; Wegienka G; Harlow SD; Alavanja M; Sandler DP
Epidemiology; 2002 Nov; 13(6):668-74. PubMed ID: 12410008
[TBL] [Abstract][Full Text] [Related]
16. The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast.
Kamenga MC; De Cock KM; St Louis ME; Touré CK; Zakaria S; N'gbichi JM; Ghys PD; Holmes KK; Eschenbach DA; Gayle HD
Am J Obstet Gynecol; 1995 Mar; 172(3):919-25. PubMed ID: 7892886
[TBL] [Abstract][Full Text] [Related]
17. Age at menopause and menopause-related symptoms in human immunodeficiency virus-infected Thai women.
Boonyanurak P; Bunupuradah T; Wilawan K; Lueanyod A; Thongpaeng P; Chatvong D; Sophonphan J; Saeloo S; Ananworanich J; Chaithongwongwatthana S
Menopause; 2012 Jul; 19(7):820-4. PubMed ID: 22549170
[TBL] [Abstract][Full Text] [Related]
18. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
[TBL] [Abstract][Full Text] [Related]
19. Anorectal surgery in patients infected with human immunodeficiency virus: factors associated with delayed wound healing.
Lord RV
Ann Surg; 1997 Jul; 226(1):92-9. PubMed ID: 9242343
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
